Headache Flashcards
Hemicrania Continua
Features?
Frequency? Duration?
Treatment?
TAC headache - Restless/agitation and/or least 1 autonomic sign (eyelid edema, conjunctival injection, lacrimation, partial Horner’s, rhinorrhea/congestion, ear fullness)
Usually unilateral and severe
Continuous at least 3 months w/ moderate to severe exacerbations.
Indomethacin - trial at high dose. Patient should respond completely within a week
more common in women
Paroxysmal Hemicrania
Clinical features?
Frequency? Duration?
Treatment?
TAC headache - Restless/agitation and/or least 1 autonomic sign (eyelid edema, conjunctival injection, lacrimation, partial Horner’s, rhinorrhea/congestion, ear fullness)
At least 20 attacks, lasting 2-30minutes, occur >5 times a day more than 50% of the time
Indomethacin - trial at high dose. Patient should respond completely within a week
more common in women
Cluster Headache
Clinical Features?
Frequency and duration?
Treatment?
TAC headache - Restless/agitation and/or least 1 autonomic sign (eyelid edema, conjunctival injection, partial Horner’s, rhinorrhea/congestion, ear fullness)
At least 5 attacks lasting 15-180 minutes, 1-sided severe temporal, orbital, or supraorbital pain, occurring qod - 8x a day at least 50% of the time during a cluster cycle.
Does not respond to Indomethacin.
Acute: Oxygen therapy, rapid triptan (subq or intranasal sumatriptan, intranasal zolmitriptan)
Preventative: “Verapamil +” ….VPA, lithium, melatonin
more common in men
Trigeminal Neuralgia
Clinical Features?
Freq and duration?
Treatment?
Dx?
No autonomic features. Not a TAC. Classified as “Painful cranial neuropathy”
At least three attacks of unilateral face pain in trigeminal distribution w/o radiation. At least 3 of: Recurrent, lasts a second to two minutes, severe, shooting/electric/stabbing, precipitated by stimuli like chewing or touch,.
Carbamazepine is first line. Can try gabapentin, topirimate
Bilateral or young woman, evaluate for MS, lyme, sarcoidosis, other secondary causes
SUNCT and SUNA
Clinical Features?
Frequency and duration?
Treatment?
Short-lasting Unilateral Neuralgiform headache with Conjunctival injection and Tearing
Short-lasting Unilateral Neuralgiform headache with cranial Autonomic symptoms
TAC headaches - Restless/agitation and/or least 1 autonomic sign (eyelid edema, conjunctival injection, partial Horner’s, rhinorrhea/congestion, ear fullness).
1-sided mod-severe temporal, orbital, supraorbital, or trigeminal pain
At least 20 attacks lasting 1-600 seconds either individually or in clusters, at least once daily (usually much more) at least 50% of the time during a cycle.
SUNCT = needs injection and lacrimation. SUNA = can have one or neither of those
Does not respond to Indomethacin. more common in men
Hemiplegic migraine
Types, mechanism, and symptoms?
Diagnosis?
Familial (all AD):
1. FHM1 = CACN1A (19p13) - P/Q Ca channel subunit
- +/- cerebellar (nystagmus, ataxia), coma, prolonged hemiplegia, transient cerebral edema or atrophy, but FULL RECOVERY
- FHM2 = ATP1A2 (1q23) - A1A2 Na/K ATPase channel
- recurrent coma, frequent/long-lasting hemiplegia, seizures, ID. NO ataxia - FHM3 = SCN1A (2q24) - defects in pre- and post-synaptic voltage-gated Na channels
At least 2 attacks w/ aura of fully reversible motor weakness +/- sensory, visual, and/or speech symptoms. Also 2 of following:
A. headache w/ aura or within 60mins of cessation, B. one or more aura symptom that spread over 5 minutes and/or two or more develop in succession, each motor aura lasts <72 hours,
Sumatriptan
Use? MoA? Side effects? Contraindications? Metabolism
Seratonin Agonist
Use:
- abortive treatment for migraines (1st line)
Mech of Action:
- increases cerebral artery vasoconstriction, 5HT1B/1D agonist in cerebral vessels, preventing vasodilator release and inhibiting trigeminal nerve activation
- Must be used early in HA for effect
Side Effects:
- Coronary vasospasm
- mild tingling
Contraindications:
- CAD, Prinzmetal’s Angina
Metabolism:
- Half-life <2h
Di-hydroergotamine
Ergot Alkaloid
Use:
- abortive treatment for migraines
Mech of Action:
- Partial agonist at vascular α and 5HT2 receptors, causing vasoconstriction of cerebral vessels
Side Effects:
Contraindications:
- do not use within 24 hours of triptans
Metabolism:
Eptinezumab
Fremanezumab (Ajovy)
Galcanezumab (Emgality)
Erenumab (Aimovig)
CGRP Monoclonal Abs
- Abortive and preventive therapy
- Erenumab only one that targets CGRP receptor, not ligand (“E aims for the receptor”)